✦ LIBER ✦

MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial

✍ Scribed by Lorinda Chung; Lee Shapiro; David Fiorentino; Murray Baron; Joseph Shanahan; Sangeeta Sule; Vivien Hsu; Naomi Rothfield; Virginia Steen; Richard W. Martin; Edwin Smith; Maureen Mayes; Robert Simms; Janet Pope; Bashar Kahaleh; M. E. Csuka; Barry Gruber; David Collier; Nadera Sweiss; Adam Gilbert; Frederick J. Dechow; Jeffrey Gregory; Fredrick M. Wigley

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 88 KB
Volume: 60
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.24351

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of vascular damage in sclerod

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril

✍ A. E. Gliddon; C. J. Doré; C. M. Black; N. McHugh; R. Moots; C. P. Denton; A. He 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and tolerability of prolonged administration of quinapril, a long‐acting angiotensin‐converting enzyme inhibitor, in the management of the peripheral vascular manifestations of limited cutaneous systemic sclerosis (lcSSc) and in the prevention of t